Columns
- Anatomy of a Managed Partnership
-
Michel Abiteboul, vice president of global business development at NovaQuest, outlines various partnering solutions for today’s global pharmaceutical marketplace.
- Safety through Standards
-
Paula Brown Stafford, executive vice president of global data management at Quintiles, discusses how universal data standards can help ensure better patient safety across all phases of clinical research.
- A New Gold Standard for Pricing
-
Dr. John Doyle, practice leader for market access at Quintiles Consulting, introduces the concept of a health economic balance sheet and evidence-based pricing for biopharmaceutical valuation.
- Challenge Accepted
-
Kathleen Marley-Matts, managing director of Quintiles Medical Education, discusses the challenges and opportunities in providing objective CME programming.
- Cultivating Safety
-
Axel Olsen, Ph.D., executive director of global pharmacovigilance and risk management at Quintiles, discusses the need for a new culture of safety in the life sciences sector.
- A Delicate Balance
-
Leslie Cate, vice president of access to patients at Quintiles, explains how building relationships with investigators improves recruitment and reduces clinical trial timelines.
- A New Culture of Safety
-
Dr. Hugo Stephenson, senior executive at Quintiles, encourages pharmaceutical manufacturers, regulators and investigators to embrace a new model for post-marketing studies.
- Safeguarding Subjects
-
Dr. Tim Mant, senior medical adviser at Guy’s Drug Research Unit for Quintiles, explains the importance of protecting volunteer safety in early clinical trials.
- A Guiding Hand
-
As with many aspects of biotechnology, the process of shepherding an emerging product from the laboratory to the patient is full of uncertainties.
- Respectful Research
-
Judith Beach, senior associate general counsel for regulatory and government affairs, and chief privacy officer at Quintiles Transnational, discusses the importance of applying relevant ethical standards when conducting global research.
Web Exclusives
- An Unbalanced Burden
-
A Q&A with Dr. Kathleen Squires, director of the infectious disease department at Jefferson Medical College in Philadelphia, illuminates the gender differences in the diagnosis and treatment of HIV.
- Turning the Corner
-
After decades of neglect, leading to a rapid increase in incidence, tuberculosis started gaining attention from industrialized nations over the past 10 years. With this new focus, TB’s incidence has started to decrease—but barely.